This inventor holds 1 USPTO granted patent. Top assignee: Universitätsmedizin Der Johannes Gutenberg-Univsersität Mainz. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Christine Zimmermann: Innovator in HCMV Vaccine Development
Introduction
Christine Zimmermann is a prominent inventor based in Wiesbaden, Germany. She has made significant contributions to the field of medicine, particularly in the development of vaccines. Her innovative work focuses on the human cytomegalovirus (HCMV), which poses a considerable health risk.
Latest Patents
Zimmermann holds a patent for a recombinant human cytomegalovirus (HCMV) strain. This invention relates to nucleic acid molecules encoding the HCMV strain, as well as dense bodies produced by this strain. The preparations of these dense bodies are intended for use in medicine, specifically as a vaccine against HCMV. She has 1 patent to her name.
Career Highlights
Christine Zimmermann is affiliated with Universitätsmedizin der Johannes Gutenberg-Universität Mainz, where she conducts her research and development work. Her career is marked by a commitment to advancing medical science and improving public health through innovative vaccine solutions.
Collaborations
Zimmermann collaborates with Bodo Plachter, a fellow researcher in her field. Their partnership enhances the research efforts aimed at combating HCMV and developing effective vaccines.
Conclusion
Christine Zimmermann's work in HCMV vaccine development exemplifies the impact of innovative research in medicine. Her contributions are vital in the ongoing fight against viral infections, showcasing the importance of scientific advancement in public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile